{
  "title": "Boosters Won't Make It To Everyone For Now, But Vaccines For Young Children Are Coming",
  "description": "The FDA Advisory Committee decided not to approve boosters for people sixteen and up. Instead, they made a recommendation for those 65 and up, or younger people at high risk to get a booster shot right now from Pfizer-Biontech.",
  "pubDate": "Tue, 21 Sep 2021 17:00:24 -0400",
  "copyright": "Copyright 2020-2021 NPR - For Personal Use Only",
  "guid": "dca88a2c-a7f7-467d-aef0-f219257ab9cc",
  "link": "https://www.npr.org/2021/09/21/1039301398/boosters-wont-make-it-to-everyone-for-now-but-vaccines-for-young-children-are-co",
  "itunes:title": "Boosters Won't Make It To Everyone For Now, But Vaccines For Young Children Are Coming",
  "itunes:author": "NPR",
  "itunes:summary": "The wider population of Americans will have to continue to wait to get a COVID booster shot. In the meantime, vaccinations for children 5 to 11 are nearly approval.",
  "itunes:subtitle": "The wider population of Americans will have to continue to wait to get a COVID booster shot. In the meantime, vaccinations for children 5 to 11 are nearly approval.",
  "itunes:image": "",
  "itunes:duration": 712,
  "itunes:explicit": "no",
  "itunes:episodeType": "full",
  "content:encoded": "The FDA Advisory Committee decided not to approve boosters for people sixteen and up. Instead, they made a recommendation for those 65 and up, or younger people at high risk to get a booster shot right now from Pfizer-Biontech.",
  "enclosure": ""
}